Algo version: 0.98b
Incyte Corporation is listed at the LSE Exchange
Incyte Corporation [0J9P.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Incyte Corporation stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Incyte Corporation pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.285 per share. Over the last 1 times between 2022 and 2022, Incyte Corporation has paid $0.285 with an average of $0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Incyte Corporation 10 years ago, but if you had invested on Tuesday 10th of August 2021 when the price was $73.15, you would have made a loss of $-2.26 per share or -3.09%

No, the average daily trading liquidity for Incyte Corporation is $2 831 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Incyte Corporation has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 0.80%, which is challenging.

We have calculated the inflation risk for Incyte Corporation to be low [0.5 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.